Lataa...
Expression of PTEN‐long mediated by CRISPR/Cas9 can repress U87 cell proliferation
PTEN is a tumour suppressor that is frequently mutated in a variety of cancers. Hence, PTEN has significant potential as a therapeutic molecule. PTEN‐long is an alternative translation variant, with an additional 173 amino acids added to the N‐terminal of the canonical PTEN when CUG of the mRNA is u...
Tallennettuna:
| Julkaisussa: | J Cell Mol Med |
|---|---|
| Päätekijät: | , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5706501/ https://ncbi.nlm.nih.gov/pubmed/28631420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13236 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|